◂ Announcements

Medical Devicesworld trade 2024+5.1% 5Y CAGR

Feb 19, 2021CONTRACTCanada

Algernon Pharmaceuticals awards DMT manufacturing contract to Dalton Pharma Services

Algernon Pharmaceuticals awarded a contract to Dalton Pharma Services to manufacture the active pharmaceutical ingredient and finished product for its DMT formulation (AP-188) for a stroke program. Work has begun on the synthesis.

Status

Announced

ProductsDMT active pharmaceutical ingredientfinished drug product

CompaniesAlgernon Pharmaceuticals customer Dalton Pharma Services supplier

Sectors#Medical Devices

“We are very pleased to have appointed Dalton Pharma Services to synthesize our GMP DMT supply.”dalton.com

1 source
dalton.comAlgernon Pharmaceuticals Awards Stroke Program Contract to Dalton PharmaFeb 19, 2021

Summarized from public sources; check the original articles before acting on it.

Similar announcements

Apr 28, 2026CONTRACTCanada$500K
Medicalgorithmics receives $500K order for Kardiobeat.ai devices from Canadian partner
Medicalgorithmics medicalgorithmics.com
Dec 1, 2025CONTRACTCanada$5.90M
Medicalgorithmics signs USD 5.9 million contract for Kardiobeat devices with Canadian partner
Medicalgorithmics supplier medicalgorithmics.com
May 1, 2025CONTRACTOntario, Canada$65.0M
Emergent BioSolutions signs $65M contract to supply NARCAN Nasal Spray to Ontario Ministry of Health
Emergent BioSolutions supplier Ontario Ministry of Health customer quiverquant.com
Nov 9, 2026CONTRACTKuala Lumpur, Malaysia, Malaysia$4.40M
BCM Alliance secures RM19.68M medical equipment supply contract
BCM Alliance Bhd Maymedic Technology Sdn Bhd theedgemalaysia.com endata.com
Nov 9, 2026CONTRACTMalaysia$19.6M
UEM Edgenta unit wins RM91.8M biomedical maintenance contract
UEM Edgenta Bhd Edgenta Healthtronics Sdn Bhd theedgemalaysia.com endata.com
Nov 7, 2026CONTRACTSouth Korea$325.0M
Samsung Biologics signs $325M manufacturing pact with Celltrion
Samsung Biologics supplier Celltrion customer inforcapital.com

Loading…